Correlation Between Marker Therapeutics and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Marker Therapeutics and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marker Therapeutics and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marker Therapeutics and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Marker Therapeutics and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marker Therapeutics with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marker Therapeutics and Acrivon Therapeutics,.
Diversification Opportunities for Marker Therapeutics and Acrivon Therapeutics,
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Marker and Acrivon is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Marker Therapeutics and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Marker Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marker Therapeutics are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Marker Therapeutics i.e., Marker Therapeutics and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Marker Therapeutics and Acrivon Therapeutics,
Given the investment horizon of 90 days Marker Therapeutics is expected to generate 1.76 times more return on investment than Acrivon Therapeutics,. However, Marker Therapeutics is 1.76 times more volatile than Acrivon Therapeutics, Common. It trades about 0.09 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest 339.00 in Marker Therapeutics on September 12, 2024 and sell it today you would earn a total of 59.00 from holding Marker Therapeutics or generate 17.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Marker Therapeutics vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Marker Therapeutics |
| Acrivon Therapeutics, |
Marker Therapeutics and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Marker Therapeutics and Acrivon Therapeutics,
The main advantage of trading using opposite Marker Therapeutics and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marker Therapeutics position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Marker Therapeutics vs. Lumos Pharma | Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |